iconEarnings Announcement After Market Close

Biomarin Pharmaceutical Inc BMRN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:21 PM EDT
88.02quote price arrow down-3.18 (-3.49%)
Volume
71,946
Close
91.20quote price arrow down-0.86 (-0.93%)
Volume
1,503,079
52 week range
76.02 - 99.56
Loading...
  • Open92.69
  • Day High93.01
  • Day Low91.00
  • Prev Close92.06
  • 52 Week High99.56
  • 52 Week High Date12/14/23
  • 52 Week Low76.02
  • 52 Week Low Date11/02/23

Key Stats

  • Market Cap17.307B
  • Shares Out189.77M
  • 10 Day Average Volume1.67M
  • Dividend-
  • Dividend Yield-
  • Beta0.30
  • YTD % Change-5.41

KEY STATS

  • Open92.69
  • Day High93.01
  • Day Low91.00
  • Prev Close92.06
  • 52 Week High99.56
  • 52 Week High Date12/14/23
  • 52 Week Low76.02
  • 52 Week Low Date11/02/23
  • Market Cap17.307B
  • Shares Out189.77M
  • 10 Day Average Volume1.67M
  • Dividend-
  • Dividend Yield-
  • Beta0.30
  • YTD % Change-5.41

RATIOS/PROFITABILITY

  • EPS (TTM)0.88
  • P/E (TTM)103.87
  • Fwd P/E (NTM)53.08
  • EBITDA (TTM)262.483M
  • ROE (TTM)3.51%
  • Revenue (TTM)2.419B
  • Gross Margin (TTM)78.72%
  • Net Margin (TTM)6.93%
  • Debt To Equity (MRQ)21.96%

EVENTS

  • Earnings Date04/24/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biomarin Pharmaceutical Inc

 

Profile

MORE
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme...
Richard Meier
Non-Executive Independent Chairman of the Board
Alexander Hardy
President, Chief Executive Officer, Director
Brian Mueller CPA
Chief Financial Officer, Executive Vice President - Finance
Erin Burkhart
Group Vice President, Chief Accounting Officer
C. Greg Guyer Ph.D.
Executive Vice President - Global Manufacturing and Technical Operations, Chief Technical Officer
Address
105 Digital Dr
Novato, CA
94949-8703
United States

Top Peers

SYMBOLLASTCHG%CHG
RPRX
Royalty Pharma PLC
27.98+0.16+0.58%
UTHR
United Therapeutics Corp
237.00+2.53+1.08%
CTLT
Catalent Inc
55.95-0.08-0.14%
IONS
Ionis Pharmaceuticals Inc
42.45+0.61+1.46%
AMRX
Amneal Pharmaceuticals Inc
6.05+0.65+12.04%